Christina Y. Weng, MD, MBA, FASRS

Christina Y. Weng, MD, MBA, FASRS, is professor and the Alice R. McPherson Retina Research Foundation Chair in Ophthalmology, and fellowship program director, vitreoretinal diseases and surgery with Baylor College of Medicine in Houston, Texas.

Articles by Christina Y. Weng, MD, MBA, FASRS

Retina Society 2026: Could statins reduce PVR risk after RD repair?

ByChristina Y. Weng, MD, MBA, FASRS,Sheryl Stevenson

September 26th 2026

Christina Y. Weng, MD, MBA, FASRS, highlights findings showing statin use reduced PVR risk by 25% in a propensity-matched cohort of nearly 10,000 patients.

(Image credit: Christina Weng/Darius Bordbar/Asad Loya)

The Retina TL;DR with Dr. Weng: Advice for retina fellowship success with Darius Bordbar, MD, and Asad Loya, MD

ByChristina Y. Weng, MD, MBA, FASRS,Darius Bordbar, MD,Asad Loya, MD

September 25th 2026

In the latest episode of The Retina TL;DR with Dr. Weng—part 1 of a special two-part series—host Christina Y. Weng, MD, MBA, FASRS, sits down with two of her former residents, now second-year surgical retina fellows, for candid advice on matching, transitioning, and thriving in fellowship.

(Image credit: Christina Y. Weng, MD, MBA, FASRS, and Thomas M. Aaberg Jr., MD) The Retina TL;DR with Dr. Weng: Marking a milestone in MacTel with Thomas M. Aaberg Jr., MD

The Retina TL;DR with Dr. Weng: Marking a MacTel milestone with Thomas M. Aaberg Jr., MD

ByChristina Y. Weng, MD, MBA, FASRS,Thomas M. Aaberg Jr., MD

September 11th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Aaberg about the science, clinical data, and real-world reception of the first FDA-approved treatment for MacTel type 2.

(Image credit: Modern Retina) The Retina TL;DR with Dr. Weng: Harnessing home OCT and Protocol AO for wet AMD with Christina J. Flaxel, MD, FARVO, and Noam Rudnick, MD, PhD

The Retina TL;DR with Dr. Weng: Harnessing home OCT and Protocol AO for wet AMD with Christina J. Flaxel, MD, FARVO, and Noam Rudnick, MD, PhD

ByChristina Y. Weng, MD, MBA, FASRS,Christina J. Flaxel, MD, FARVO,Noam Rudnick, MD, PhD

August 15th 2026

Host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Flaxel and Dr. Rudnick about how a home monitoring device could reshape treatment decisions and reduce office visits for patients with wet AMD.

The Retina TL;DR with Dr. Weng: Restoring central vision in geographic atrophy with PRIMA and Frank Brodie, MD, MBA

ByChristina Y. Weng, MD, MBA, FASRS,Frank Brodie, MD, MBA

July 16th 2026

In the latest episode of The Retina TL;DR with Dr. Weng, host Christina Y. Weng, MD, MBA, FASRS, talks with Dr. Brodie about a photovoltaic subretinal implant showing meaningful visual gains in patients with geographic atrophy due to AMD.

Christina Y. Weng, MD, MBA, FASRS

Articles by Christina Y. Weng, MD, MBA, FASRS

Retina Society 2026: Could statins reduce PVR risk after RD repair?

The Retina TL;DR with Dr. Weng: Advice for retina fellowship success with Darius Bordbar, MD, and Asad Loya, MD

The Retina TL;DR with Dr. Weng: Marking a MacTel milestone with Thomas M. Aaberg Jr., MD

The Retina TL;DR with Dr. Weng: Harnessing home OCT and Protocol AO for wet AMD with Christina J. Flaxel, MD, FARVO, and Noam Rudnick, MD, PhD

The Retina TL;DR with Dr. Weng: Restoring central vision in geographic atrophy with PRIMA and Frank Brodie, MD, MBA

Latest Updated Articles

Trending on Eye Care Network - Ophthalmology Times

FDA approves subcutaneous Enspryng for TED

AAO 2026: Vamikibart shows sustained gains in uveitic macular edema as FDA accepts BLA

OT Roundup: Optogenetics Nobel Prize, BRUNELLO, DRAGON, eye transplant

EC-104 outperforms Ozurdex in phase 2 BETTIS-1 trial for anti-VEGF–resistant DME

Introducing Noah Banoub: The medical student’s path from church pews to the retina clinic